FDA Review of Approved Drug, Ubrogepant, Included DILIsym Simulations

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. AAPL
4. SPGI
5. USO
6. DELL
7. ENOV
8. AON
9. NIO
10. A

Go back to FDA Review of Approved Drug, Ubrogepant, Included DILIsym Simulations
SIMULATIONS PLUS, Inc. (NASDAQ: SLP) Delayed: 18.42 +0.02 (0.11%)
Previous Close $18.40    52 Week High $11.89 
Open $18.39    52 Week Low $6.74 
Day High $18.42    P/E 102.33 
Day Low $18.39    EPS $0.18 
Volume 173,829